BIO-Key International Current Assets
The Current Assets of BIO-Key International (BKYI) as of Aug 22, 2026 is 3.36 M USD. In the previous year, Current Assets was 1.89 M USD — a change of 77.84% (higher).
Get this data via API
Financial Data API
Current Assets
3.36 MUSD
YoY
77.84%
Last updated:
The BIO-Key International Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 3.36 MUSD | +77.84% | |
| 1.89 MUSD | -28.04% | |
| 2.62 MUSD | -70.81% | |
| 8.98 MUSD | -35.89% | |
| 14.01 MUSD | -26.02% | |
| 18.94 MUSD | +1,283.02% | |
| 1.37 MUSD | -67.62% | |
| 4.23 MUSD | -39.75% | |
| 7.02 MUSD | +42.84% | |
| 4.91 MUSD | -62.77% | |
| 13.20 MUSD | +636.48% | |
| 1.79 MUSD | -25.22% | |
| 2.40 MUSD | +165.28% | |
| 903,263.00USD | +28.93% | |
| 700,595.00USD | -81.65% | |
| 3.82 MUSD | +21.96% | |
| 3.13 MUSD | +62.90% | |
| 1.92 MUSD | -42.99% | |
| 3.37 MUSD | -14.69% | |
| 3.95 MUSD | +15.95% | |
| 3.41 MUSD | -19.76% | |
| 4.25 MUSD | +215.93% | |
| 1.34 MUSD | +876.84% | |
| 137,645.00USD | -80.93% | |
| 721,604.00USD | +795.57% | |
| 80,575.00USD | -56.86% | |
| 186,772.00USD | -88.65% | |
| 1.65 MUSD | -58.73% | |
| 3.99 MUSD | +1,743.17% | |
| 216,336.00USD | +621.12% | |
| 30,000.00USD | — |
BIO-Key International Stock analysis
Frequently Asked Questions about BIO-Key International stock
Current Assets of BIO-Key International is 3.36 M USD in 2026.
Current Assets of BIO-Key International changed from 1.89 M USD to 3.36 M USD, representing a 77.84% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Current Assets BIO-Key International since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's BIO-Key International historically and in real time.
Balance Sheet — BIO-Key International
All Key Metrics — BIO-Key International
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth